New Key Statistics Module, Z-Score and F-Score
XCNQ:DMED Key Ratios
Market Cap C$ M | 3.20 |
Enterprise Value C$ M | 2.74 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 11.67 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.02 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.60 |
EV-to-EBITDA | -2.60 |
PEG | -- |
Shares Outstanding M | 80.05 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 2.00 |
Current Ratio | 2.00 |
ROA % (ttm) | -104.41 |
ROE % (ttm) | -176.03 |
ROIC % (ttm) | -- |
Dividend Yield % | -- |
Altman Z-Score | -- |
XCNQ:DMED Number of Guru Trades
XCNQ:DMED Volume of Guru Trades
Gurus Latest Trades with XCNQ:DMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:DMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Diagnamed Holdings Corp Insider Transactions
No Available Data